Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: Randomized phase II study.
Annals of Oncology.
Times cited: 5
The impact of sharing results of a randomized breast cancer clinical trial with study participants.
Breast Cancer Research and Treatment.
Times cited: 15